Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chinese Patent Office
Cipla
Express Scripts
Covington
UBS
Harvard Business School
Citi
Deloitte
Mallinckrodt

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076064

« Back to Dashboard

NDA 076064 describes JUNEL FE 1.5/30, which is a drug marketed by Barr and is included in one NDA. It is available from five suppliers. Additional details are available on the JUNEL FE 1.5/30 profile page.

The generic ingredient in JUNEL FE 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 076064
Tradename:JUNEL FE 1.5/30
Applicant:Barr
Ingredient:ethinyl estradiol; norethindrone acetate
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 076064
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
JUNEL FE 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 076064 ANDA Teva Pharmaceuticals USA, Inc. 0555-9028 0555-9028-58 6 POUCH in 1 CARTON (0555-9028-58) > 1 BLISTER PACK in 1 POUCH > 1 KIT in 1 BLISTER PACK
JUNEL FE 1.5/30 ethinyl estradiol; norethindrone acetate TABLET;ORAL-28 076064 ANDA Rebel Distributors Corp 42254-242 42254-242-28 1 KIT in 1 BLISTER PACK (42254-242-28)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.03MG;1.5MG
Approval Date:Sep 18, 2003TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
AstraZeneca
Chinese Patent Office
Dow
Boehringer Ingelheim
Deloitte
Johnson and Johnson
Baxter
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot